Boston and Barcelona — February 23, 2026 — Pharmacelera, a deep-tech company developing and applying high-accuracy Quantum Mechanics and Artificial Intelligence (“deep physics”) algorithms to design therapies for unmet medical needs, today announced the appointment of Dr. Cynthia White Tingle as Head of U.S. Operations and Business Development.

Dr. Tingle holds a PhD in Organic Chemistry from Brown University and brings more than two decades of corporate and business development and customer success experience delivering advanced computing solutions to biopharma R&D and intellectual property teams. She has held senior leadership, commercial, and customer-facing roles at CambridgeSoft, CAS, Chemaxon, and Optibrium.

“Cynthia will play a pivotal role in advancing Pharmacelera’s growth strategy in the United States,” said Dr. Enric Gibert, CEO and Co-founder of Pharmacelera. “Her experience and leadership will be instrumental in building a strong US-based scientific team and expanding our collaborations with pharmaceutical companies, biotech firms, and research institutions across North America, always with a science-first and customer-focused approach”, he added.

“The integration of accurate Quantum Mechanics algorithms to model 3D molecular interactions with Artificial Intelligence methods capable of exploring ultra-large chemical spaces represents a meaningful step forward in strengthening intellectual property in drug discovery,” said Dr. Tingle. “Identifying novel and diverse active starting points is essential — but equally critical is the ability to progress them and design differentiated drug candidates”, she added.